ESTIMATING THE IMPACT OF DELAYED TREATMENT FOR MAJOR DEPRESSIVE DISORDER USING A CONTINUOUSTIME PATIENT-LEVEL SIMULATION MODEL

被引：0
|
作者：
Chapman, R. [1 ]
Cheng, M. [1 ]
Xie, R. [2 ]
机构：
[1] Innovat & Value Initiat, Alexandria, VA USA
[2] RA Capital Management, Newton, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE501
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [31] Wisdom of the CROUD: Development and validation of a patient-level prediction model for opioid use disorder using population-level claims data
    Reps, Jenna Marie
    Cepeda, M. Soledad
    Ryan, Patrick B.
    PLOS ONE, 2020, 15 (02):
  • [32] Individual variability in treatment response to antidepressants in major depression: comparing trial-level and patient-level analyses
    Hieronymus, F.
    Hieronymus, M.
    Nilsson, S.
    Eriksson, E.
    Ostergaard, S. D.
    ACTA PSYCHIATRICA SCANDINAVICA, 2020, 142 (06) : 443 - 445
  • [33] The impact of treatment on quality of life in major depressive disorder (MDD) and generalized anxiety disorder (GAD)
    Demyttenaere, K.
    EUROPEAN PSYCHIATRY, 2008, 23 : S201 - S201
  • [34] Clinical and economic impact of first-line or drug-naïve catheter ablation and delayed second-line catheter ablation for atrial fibrillation using a patient-level simulation model
    Arbelo, Elena
    De Ponti, Roberto
    Cohen, Lucas
    Pastor, Laura
    Costa, Graca
    Hempel, Marike
    Grima, Daniel
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1168 - 1179
  • [35] Predicting Treatment Response in Major Depressive Disorder: The Impact of Early Symptomatic Improvement
    Kudlow, Paul A.
    Cha, Danielle S.
    McIntyre, Roger S.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (12): : 782 - 788
  • [36] Impact of Drug Tolerability on the Selection of Antidepressant Treatment in Patients With Major Depressive Disorder
    Ginsberg, Lawrence D.
    CNS SPECTRUMS, 2009, 14 (12) : 8 - 14
  • [37] The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder
    Rovers, J. J. E.
    Vissers, P.
    Loef, D.
    van Waarde, J. A.
    Verdijk, J. P. A. J.
    Broekman, B. F. P.
    Vergouwen, A. C. M.
    Oudega, M. L.
    van Exel, E.
    Coenen, R.
    Everaerd, D. S.
    Tendolkar, I.
    Dols, A.
    van Eijndhoven, P. F. P.
    ACTA PSYCHIATRICA SCANDINAVICA, 2023, 147 (06) : 570 - 580
  • [38] PATIENT-LEVEL MARKOV MODEL TO ASSESS ECONOMIC IMPACT OF NEW ANTIPSYCHOTICS INTRODUCTION IN SCHIZOPHRENIA
    Millier, A.
    Vimont, A.
    Cadi-Soussi, N.
    Murthy, V
    Toumi, M.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [39] DEVELOPMENT OF A SEQUENCING MODEL USING PATIENT-LEVEL DATA TO OPTIMIZE PATIENT OUTCOMES IN MULTIPLE MYELOMA
    Mendes, J.
    Boer, J. H.
    Casamassima, G.
    Willis, A.
    Matthijsse, S.
    Armeni, P.
    VALUE IN HEALTH, 2022, 25 (01) : S202 - S202
  • [40] Estimating the Potential Economic Impact of Tissue Valve Replacement for Heart Valve Disease in China: Patient-Level and Population-Level Cost-Benefit Simulation Analyses
    Wang, Bruce
    Wu, Elizabeth
    Rassloff, Dirk
    Moore, Matt
    Bridger, Perry
    Garrison, Louis P.
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 35 : 19 - 26
12345